[Macrophagic myofasciitis: inflammatory, vaccination-associated muscular disease]

Dtsch Med Wochenschr. 2003 Oct 31;128(44):2305-8. doi: 10.1055/s-2003-43184.
[Article in German]

Abstract

History and admission findings: A 67-year-old man presented with a 6-week history of slowly progressive muscle pain and generalized muscular weakness. Neurological examination showed symmetrical proximal weakness (MRC grade 4/5).

Investigations: Laboratory tests revealed an elevated CK level of 124 U/l (normal < 80). Needle EMG showed pathological spontaneous activity in proximal muscle groups. A diagnostic muscle biopsy taken from the left deltoid muscle revealed a characteristic infiltrate of PAS-positive and acid phosphatase-positive macrophages. Electron microscopic analysis of muscle tissue failed to demonstrate aluminium hydroxide inclusion. Serological analysis excluded antibodies against HAV and HBV but was compatible with a previous tetanus vaccination (antibody titre of 2.3 IE/ml).

Treatment: A 2-year treatment with steroids and azathioprine led to complete recovery of muscle strength without relapse after discontinuing the immunosuppression.

Conclusion: Macrophagic myofasciitis (MMF) is a rare inflammatory muscle disorder characterized by a characteristic infiltration of muscle tissue by PAS-positive macrophages, which is caused by pathological persistence of vaccine-derived aluminium hydroxide. The diagnosis can only be established by an open muscle biopsy from the muscle that was used for intramuscular vaccination.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use
  • Biopsy
  • Electromyography
  • Fasciitis / diagnosis
  • Fasciitis / drug therapy
  • Fasciitis / etiology*
  • Fasciitis / pathology
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Injections, Intramuscular
  • Macrophages*
  • Male
  • Muscles / pathology
  • Myositis / diagnosis
  • Myositis / drug therapy
  • Myositis / etiology*
  • Myositis / pathology
  • Tetanus Toxoid / administration & dosage
  • Time Factors
  • Vaccination / adverse effects*

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Tetanus Toxoid
  • Azathioprine